Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: neurotoxic (Click to remove) Long-Term Cognitive Function, Neuroimaging and Quality of Life in Primary CNS Lymphoma Neurol 81:84-92, Doolittle, N.,et al, 2013 Treatment and Prognosis of Primary Central Nervous System Lymphoma Up to Date Sept 2010, Hochberg,F.H.,et al, 2010 Salvage Whole Brain Radiotherapy for Recurrent or Refractory Primary CNS Lymphoma Neurol 69:1178-1182, Hottinger,A.F.,et al, 2007 NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005 Delayed Neurotoxicity in Primary Central Nervous System Lymphoma Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005 Update on Primary Central Nervous System Lymphoma Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005 Reversible Neurologic Toxicity with Fludarabine Phosphate for Mycosis Fungiodes & Chronic Lymphocytic Leukemia Ann Int Med 118:114-116, Cohen,R.B.,et al, 1993 Imaging Findings in Children Presenting with CNS Nelarabine Toxicity AJNR 43:1802-1809, Serrallach,B.L.,et al, 2022 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 CNS Complications of Radiotherapy and Chemotherapy Lancet 374:1639-1651, Soussain,C.,et al, 2009 Cisplatin Neurotoxicity Presenting as Reversible Posterior Leukoencephalopathy Syndrome AJNR 19:415-417, 5911998., Ito,Y.,et al, 1998 Showing articles 0 to 13 of 13